PW Medtech Group Limited

HKSE 1358.HK

PW Medtech Group Limited Free Cash Flow Yield on January 14, 2025: 10.25%

PW Medtech Group Limited Free Cash Flow Yield is 10.25% on January 14, 2025, a -10.90% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • PW Medtech Group Limited 52-week high Free Cash Flow Yield is 12.89% on January 31, 2024, which is 25.80% above the current Free Cash Flow Yield.
  • PW Medtech Group Limited 52-week low Free Cash Flow Yield is 7.88% on July 29, 2024, which is -23.14% below the current Free Cash Flow Yield.
  • PW Medtech Group Limited average Free Cash Flow Yield for the last 52 weeks is 9.64%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
HKSE: 1358.HK

PW Medtech Group Limited

CEO Ms. Yue'e Zhang
IPO Date Nov. 8, 2013
Location China
Headquarters Building 1
Employees 1,302
Sector Health Care
Industries
Description

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Similar companies

1345.HK

China Pioneer Pharma Holdings Limited

USD 0.30

-0.02%

1349.HK

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

USD 0.29

2.68%

StockViz Staff

January 15, 2025

Any question? Send us an email